ArticleScientific reports2025
The anticancer activity of fucoidan coated selenium nanoparticles and curcumin nanoparticles against colorectal cancer lines.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Amorphous selenium nanoparticles: synthesis strategies and multifunctional applications.RSC advances · 2026Review
- Hydrophobic Deep Eutectic Solvent-Derived Curcuminoids Loaded into a Double-Layer Colloidal Delivery System: Physicochemical Properties and In Vitro Biological Activity.Foods (Basel, Switzerland) · 2026Article
- Article
- From Biofortification to HT-29 Growth Inhibition: Selenium-Enriched Sunflower Sprouts Modulate Apoptosis- and Cell Cycle-Related Markers.Foods (Basel, Switzerland) · 2026Article
- Renaissance of Traditional Mineral Drugs in Cancer: Advanced Delivery Strategies and Bioengineering Approaches.Pharmaceutics · 2026Review
- Mineral-Phytochemical Conjugate: Synthesis, Characterization, Biological Activities and Safety of Nano selenium-curcumin Conjugate.Biological trace element research · 2026Article
- A dual-pronged strategy: multi-bioactive nanoplatform synergizes ROS antidote and iron stabilization to protect against liver ischemia-reperfusion injury.Journal of nanobiotechnology · 2026Article
- Seaweed bioactives: A comprehensive review of their nutritional, medicinal, and functional roles.iScience · 2026Review
- Phytochemical-mediated green synthesis of selenium nanoparticles using Catharanthus roseus and their physicochemical characterization, biological evaluation, and molecular docking analysis.Scientific reports · 2026Article
- Ameliorative effects of gum Arabic-coated selenium nanoparticles on Cisplatin-induced cerebellar neurotoxicity in rats.Scientific reports · 2026Article
- Gum Arabic Modulates Redox-Ionic Microenvironments via Rheology and Kinetics to Induce Selective Cytotoxicity in Colorectal Cancer Cells.Gels (Basel, Switzerland) · 2026Article
- Synthesis, spectral, thermal, and biological characterization of Se(IV) nanocomplexes derived from vitamin E and amino acid mixed ligands as a metal-drug model.Scientific reports · 2025Article
- Comparative Mechanistic Insights into Quercetin-Loaded Selenium Nanoparticles and Cisplatin in HCT116 Cells.ACS omega · 2025Article
- Fucoidan-based Nanomedicine for Hearing Loss: Emerging Roles as Carrier and Therapeutic Agent.Pharmaceutical research · 2025Review
- Antifungal Nanocomposites from Honeybee Chitosan and Royal Jelly-Mediated Nanosilver for Suppressing Biofilm and Hyphal Formation ofPolymers · 2025Article
- Marine-Derived Compounds: A New Horizon in Cancer, Renal, and Metabolic Disease Therapeutics.Marine drugs · 2025Review
- Nanomaterials in the diagnosis and treatment of gastrointestinal tumors: New clinical choices and treatment strategies.Materials today. Bio · 2025Review
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
Abstract
Cancers still globally endanger millions of people yearly; the incidences/mortalities of colorectal cancers are particularly increasing. The natural nanoparticles (NPs) and marine biopolymers were anticipated to provide effectual safe significances for managing cancers. The transformation of curcumin to nano-curcumin (NCur) was conducted with gum Arabic. The resulted NCur was utilized for the biosynthesis of selenium NPs (SeNPs), then bioactive nanocomposites (NC) from them with fucoidan (Fu) were fabricated and evaluated as candidates to suppress colorectal cancers (CaCo-2 and HT-29) cells. The NCur and NCur-synthesized SeNPs were effectually produced with mean diameters of 34.67 ± 4.32 and 5.17 ± 1.06 nm, respectively. The plain and NCs of Fu/NCur/SeNPs characterization, with infrared spectroscopy and electron microscopy, emphasized their interaction and conjugations. The entire agents/NCs had potent cytotoxic effects against cancers' lines; the NC of Fu/NCur/SeNPs was the most effectual with IC50 of 10.35 ± 0.83 and 19.44 ± 1.39 mg/L against CaCo-2 and HT-29 cells, respectively, which were significantly exceeded the action of standard cisplatin drug. The NCs led to vigorous DNA damages in CaCo-2 cancerous cells, as proved with comet assay. The ultrastructure imagining (scanning/transmission microscopy) of treated cells with Fu/NCur/SeNPs confirmed the capability of NCs to induce severe apoptosis and deformation signs in cancerous cells. The bio-based constituents of Fu/NCur/SeNPs and advocate their prospective applications for preventing/managing colorectal adenocarcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.